产品封面图

CaV1.2 Channel Antibody and Me

mbrane Fractions Kit
收藏
  • $569
  • Alomone
  • 以色列
  • LK-104C
  • 2025年07月08日
  • 见官方网站
  • 见说明书
  • 见官方网站
avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 免疫原

      见官方网站

    • 亚型

      见官方网站

    • 形态

      液体或冻干粉

    • 保存条件

      -20°C

    • 克隆性

      多克隆

    • 标记物

      见官方网站

    • 适应物种

      见官方网站

    • 保质期

      6个月

    • 抗原来源

      见说明书

    • 目录编号

      LK-104C

    • 级别

    • 库存

      大量

    • 供应商

      上海信裕生物科技有限公司

    • 宿主

      见说明书

    • 应用范围

      见官方网站

    • 浓度

      见官方网站

    • 靶点

      见官方网站

    • 抗体英文名

      CaV1.2 Channel Antibody and Membrane Fractions Kit

    • 抗体名

      CaV1.2 Channel Antibody and Membrane Fractions Kit

    • 规格

      4 Vials

    CaV1.2 Channel Antibody and Membrane Fractions Kit

    Kit Contains Anti-CaV1.2 Antibody and all Controls Necessary for Robust Western Blot Analysis
    Cat #: LK-104C
    4 Vials

    CaV1.2 Channel Overexpressed Membrane Fractions (#LX-104) are Xenopus oocyte membrane fractions overexpressing CaV1.2 Channel. CaV1.2 Channel Overexpressed Membrane Fractions are your positive control for validating Alomone Labs CaV1.2 Channel Anti-CaV1.2 antibody (#ACC-003), Guinea pig Anti-CaV1.2 (#AGP-001) and Anti-CaV1.2a (#ACC-013).

    Overexpressed Membrane Fractions are:
    ✓ Lyophilized powder
    ✓ Economical
    ✓ Shipped at room temperature (no need for dry ice and extra shipping costs)
    ✓ User-friendly & time-saving. Just add water, sample buffer and load your gel

    • Compounds
    • Scientific Background
    • Related Products
    Product Name Cat # Size
    Guinea pig Anti-CaV1.2
    AGP-001 1 x 0.2 ml
    CaV1.2 Channel Overexpressed Membrane Fractions
    LX-104 2 x 0.1 ml

    Note 

    Included with the products in this kit:
    1 x 40 µg Guinea pig Anti-CaV1.2 control peptide antigen
    1 x 0.1 ml lyophilized non-injected Xenopus oocyte overexpressed membrane fraction
    Scientific Background 

    Voltage-gated Ca2+ channels (CaV), enable the passage of Ca2+ ions in a voltage dependent manner. These heteromeric entities are formed in part by the pore-forming α1 subunit which determines the biophysical and pharmacological properties of the channel1.

    L-type Ca2+ channels make up one of three voltage-gated Ca2+ channel families. Four different α1 isoforms (CaV1.1 to CaV1.4) belong to the L-type subfamily. Structurally, each α1 subunit has four homologous domains (I-IV) and each domain has a six transmembrane section. Like many other voltage-gated channels, L-type Ca2+ channels have auxiliary subunits which are responsible for modulating the surface expression and properties of the channels2-5.

    CaV1.1 is mostly expressed in the skeletal muscle, while CaV1.4 is mainly detected in the retina. The expression of both CaV1.2 and CaV1.3 is more extensive and includes neurons, heart, smooth muscle, inner ear, retina and pancreas6. L-type Ca2+ channels are involved in and modulate a variety of physiological functions such as muscle contraction, hormone secretion, neuronal excitability and gene expression5.

    CaV1.2 undergoes various post-translational modifications. For example, it can undergo proteolytic cleavage at its C-terminal. This cleavage has been shown to take place in neurons following the activation of NMDA receptors5,7 and in the heart5,8,9. The cleaved moiety can still interact with the channel and its general purpose is to modulate channel activity5. Other postranslation modifications of the channel include phosphorylation of CaV1.2 by a number of kinases such as PKA, PKC, Src and CaMKII5. In addition, it is not surprising that phosphatases also regulate channel activity, as they are required to antagonize the activity of the various kinases known to phosphorylate CaV1.2 5.

    The fact that CaV1.2 plays a prominent role in proper cardiac function has prompted endless studies regarding its regulation. Such studies have concluded that dysregulation of the channel leads to anomalies in heart contraction and thus heart failure5. Likewise, CaV1.2 defects have been detected in autism and bipolar disorder10.


    References 
    1. Bauer, C.S. et al. (2010) Curr. Opin. Neurobiol. 20, 563.
    2. Arikkath, J. et al. (2003) Curr. Opin. Neurobiol. 13, 298.
    3. Catterall, W.A. (2000) Annu. Rev. Cell. Dev. Biol. 16, 521.
    4. Davies, A. et al. (2007) Trends Pharmacol. Sci. 28, 220.
    5. Dai, S. et al. (2009) Physiol. Rev. 89, 411.
    6. Zuccotti, A. et al. (2011) Trends Pharmacol. Sci. 32, 366.
    7. Hell, J.W. et al. (1996) Proc. Natl. Acad. Sci. U.S.A. 93, 3362.
    8. De Jongh, K.S. et al. (1996) Biochemistry 35, 10392.
    9. Gao, T. et al. (2001) J. Biol. Chem. 276, 21089.
    10. Liao, P. et al. (2010) Pflugers. Arch. 460, 353.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    $569
    上海再康生物科技有限公司
    2025年11月20日询价
    $569
    上海信裕生物科技有限公司
    2025年07月08日询价
    询价
    武汉佰瑞得生物技术有限公司
    2025年07月11日询价
    询价
    艾美捷科技有限公司
    2025年07月08日询价
    ¥5015
    北京博蕾德生物科技有限公司
    2025年05月18日询价
    CaV1.2 Channel Antibody and Membrane Fractions Kit
    $569